Natural perchlorate is believed to be of atmospheric origin, yet no systematic study has been conducted to evaluate perchlorate deposition rate and possible seasonal or spatial variations. This study evaluated perchlorate concentrations in weekly composite wet deposition samples acquired through the National Atmospheric Deposition Program from 26 sites across the continental United States, Alaska, and Puerto Rico for a 1−3 year period. Perchlorate concentrations varied from <5 ng/L to a high of 102 ng/L with a mean of 14.1 ± 13.5 ng/L for the 1578 total samples. The annual perchlorate flux by site ranged from a low of 12.5 (TX) to 157 mg/ha-year (NE) and averaged 65 ± 30 mg/ha-year for all sites. Perchlorate concentrations and flux in wet deposition were generally highest in May−August declining to lows in December−February. Average annual perchlorate flux was correlated (r > 0.5; p < 0.001) with Ca2+, K+, NH4 +, NO3 −, Cl−, and SO4 −2. Wet deposition rate of ClO4 − in the conterminous United States (excluding Alaska, Hawaii, and Puerto Rico) while diffuse, represents a potential annual net mass flux of 51 000 kg, a value comparable to the estimated annual environmental releases from other known ClO4 − sources.

Obesity and type II diabetes pose a serious human health risk. Obese or diabetic patients usually take prescription drugs that require hepatic and renal metabolism and transport, and these patients sometimes display different pharmacokinetics of these drugs. Therefore, mRNA and protein expression of drug-metabolizing enzymes (DMEs) and transporters was measured in livers and kidneys of adult wild-type and ob/ob mice, which model obesity and diabetes. mRNA expression of numerous DMEs increased by at least 2-fold in livers of male ob/ob mice, including Cyp4a14, Cyp2b10, NAD(P)H:quinone oxidoreductase 1 (Nqo1), and sulfotransferase 2a1/2. In general, expression of uptake transporters was decreased in livers of ob/ob mice, namely organic anion-transporting polypeptides (Oatps) and sodium/taurocholate cotransporting polypeptide (Ntcp). In particular, Oatp1a1 mRNA and protein expression in livers of ob/ob mice was diminished to <5% and <15% of that in wild-types, respectively. Generally, the mRNA and protein expression of efflux transporters multidrug resistance-associated proteins (Mrps) was increased in livers of ob/ob mice, particularly with Mrp4 expression being elevated by at least 6-fold and Mrp2 expression at least 3-fold in livers of ob/ob mice. In kidney, Nqo1, Mrp3, 4, Oatp1a1, and organic anion transporter 2 (Oat2) showed significant alterations with mRNA expression levels in ob/ob mice, being increased for Nqo1 and Mrp4 and decreased for Mrp3, Oatp1a1, and Oat2. In summary, the expression of a number of DMEs and transporters was significantly altered in livers and kidneys of ob/ob mice. Since expression of some DMEs and transporters is regulated similarly between mouse and human, the data from this study suggest that transporter expression in liver and kidney may be changed in patients presenting with obesity and/or type II diabetes.